Delivery Order SPE2DB22D9206-SPE2DB25FV5EJ
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $45,905 delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of May 15, 2025, represents a discrete task order issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA valued at $500 million...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,234.25 for Botox 200-unit vials by the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and carries no set-aside designation. This award represents a discrete order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $64,685 by the Defense Logistics Agency on August 26, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order is scheduled for completion by September 17, 2025, with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $11,564.25 for Botox 100-unit vials by the Defense Logistics Agency's Medical Supply Chain division. The firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, carries no set-aside designation. This award falls under DMS Pharmaceutical Group's existing single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Botox 200-unit vials. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $9,636.00. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, represents a direct procurement without set-aside designation. The award leverages DMS Pharmaceutical Group's position as a crucial...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $3,881.10. The award was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, leveraging DMS Pharmaceutical Group's established position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,762.20 by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order is expected to be completed by September 26, 2025, and will be performed at the company's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19.4K by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Botox 200 unit vials. The delivery order carries an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,937.00 by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Botox 200-unit vials. The contract carries an ultimate completion date of September 19, 2025, and involves no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D9206Indefinite Delivery Contract
- SPE2DB22D9206-SPE2DB25FV5EJDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,643.30 by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Botox 200 unit vials. The award is structured as a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and was executed without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with DLA for specialized pharmaceutical products including oncology treatments, biologics, vaccines, and specialty medications. The company's federal contracting history demonstrates sustained capability in delivering pharmaceutical products directly to military health facilities nationwide. This specific delivery order for Botox reflects the company's continued role in supporting DoD medical supply requirements through the SPE2DB program's streamlined procurement mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 9/5/25 |